The software platform being developed by Voxel AI is robust and clinically flexible.
Having successfully concluded our latest funding round, we expect to be back in an active stage of fundraising by September 2021, supported by expanded analytics and exciting new clinical data in Stroke and mTBI.
We intend to validate our platform across a variety of brain disorders.
Beyond diagnosis and predicting prognosis, we are also interested in exploring a range of applications from surgical planning to selecting subjects and supporting assessment in therapeutic clinical trials.
Our investor community will be a vital part of exploring these diverse opportunities to expand our clinical value proposition.
Let’s talk further
If you’re interested in connecting with us, please complete the contact form below; we’ll be excited to share our progress with you!